当前位置: X-MOL 学术Chem › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Reaction: Navigating the promises and perils of AI-powered drug synthesis
Chem ( IF 23.5 ) Pub Date : 2024-04-23 , DOI: 10.1016/j.chempr.2024.03.028
Rick A. Bright

Rick Bright is the chief executive of Bright Global Health and former deputy assistant secretary for preparedness and response and director of BARDA at the US Department of Health and Human Services. An international expert in biodefense, emergency preparedness, pharmaceutical innovation, and public health, Dr. Bright is a member of the Council on Foreign Relations, senior fellow of the Foreign Policy Association, and advisory board member for CEPI, FIND, the 100 Days Mission, and the National Academy of Science’s Forum on Microbial Threats. He holds a PhD in immunology from Emory University and a BS in biology and physical sciences from Auburn University at Montgomery.



中文翻译:

反应:探讨人工智能驱动的药物合成的前景和危险

里克·布莱特 (Rick Bright) 是 Bright Global Health 的首席执行官,曾任美国卫生与公众服务部负责准备和响应的副助理部长兼 BARDA 主任。 Bright 博士是生物防御、应急准备、制药创新和公共卫生领域的国际专家,是外交关系委员会成员、外交政策协会高级研究员、CEPI、FIND、百日任务顾问委员会成员,以及美国国家科学院微生物威胁论坛。他拥有埃默里大学免疫学博士学位和蒙哥马利奥本大学生物学和物理科学学士学位。

更新日期:2024-04-23
down
wechat
bug